Methylprednisolone Acetate Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Methylprednisolone Acetate Injection (injection) from Par Health, USA LLC with status Current. The shortage was first posted on Jun 16, 2022. Reported reason: Other
Shortage details
- Status
- Current
- Company
- Par Health, USA LLC
- Package NDC
- 42023-240-01
- Dosage Form
- Injection
- Presentation
- Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 42023-240-01)
- Initial Posting
- Jun 16, 2022
Reason
Other